{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-204066","form_type":"8-K","ticker":"CORZ","cik":"0001839341","company_name":"Core Scientific, Inc./tx","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.637529+00:00","generated_at":"2026-06-12T04:52:04.627263+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Core Scientific CEO Michael Levitt resigns; Adam Sullivan appointed interim CEO","bullets":["Michael Levitt resigned as CEO effective Aug 2, 2023; becomes Executive Chairman at $60k annual salary; unvested equity awards remain eligible.","Darin Feinstein resigned as Co-Chairman effective Aug 2, 2023; will continue as Board member.","Adam Sullivan appointed interim CEO effective Aug 2, 2023; previously President since May 15, 2023; no related party transactions.","Sullivan oversaw over $5 billion in transactions at XMS Capital Partners; advised on Power & Digital Infrastructure acquisition of Legacy Core."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-204066","json":"https://secwatch.observer/filing/0001193125-23-204066.json","markdown":"https://secwatch.observer/filing/0001193125-23-204066.md","text":"https://secwatch.observer/filing/0001193125-23-204066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/d542047d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:52:04.627263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0db53bc5bb","claim":"Darin Feinstein resigned as Co-Chairman at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, Darin Feinstein informed the Board of his intention to resign from his position as Co-Chairman of the Board, effective as of August 2, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Co-Chairman"}],"fact_type":"executive_change"},{"claim_id":"107c07bc8f","claim":"Michael Levitt resigned as Chief Executive Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, Michael Levitt resigned from his role as Chief Executive Officer (“CEO”) of Core Scientific, Inc. (the “Company”), effective as of August 2, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"717b0298d3","claim":"Adam Sullivan was appointed as interim Chief Executive Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, the Board appointed Adam Sullivan to serve as interim CEO, effective as of August 2, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}